(Q41661659)

6 October 2017

1 reference

title

Clinical applications of zolmitriptan (Zomig, 311C90). (English)

1 reference

6 October 2017

1

R B Lipton

1 reference

6 October 2017

W F Stewart

2

1 reference

6 October 2017

language of work or name

English

0 references

publication date

1 October 1997

1 reference

6 October 2017

1 reference

6 October 2017

volume

17 Suppl 18

1 reference

6 October 2017

page(s)

53-59

1 reference

Prevalence and impact of migraine

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1807

Diagnostic testing for the evaluation of headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1807

Grading the severity of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1807

The burden of migraine. A review of cost to society

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1807

Burden of migraine: societal costs and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1807

311C90: increasing the options for therapy with effective acute antimigraine 5HT1B/1D receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1807

Efficacy of subcutaneous sumatriptan in the acute treatment of early-morning migraine: a placebo-controlled trial. Early-Morning Migraine Sumatriptan Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1807

Multicenter prospective evaluation of proposed pediatric migraine revisions to the IHS criteria. Pediatric Headache Committee of the American Association for the Study of Headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1807

311C90: long-term efficacy and tolerability profile for the acute treatment of migraine. International 311C90 Long-Term Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1807

Joint 1994 Wolff Award Presentation. Migraine and major depression: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1807

Serotonin syndrome complicating migraine pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1807

Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig, 311C90)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1807

The clinical pharmacokinetics of zolmitriptan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1807

Tolerability profile of zolmitriptan (Zomig; 311C90), a novel dual central and peripherally acting 5HT1B/1D agonist. International clinical experience based on > 3000 subjects treated with zolmitriptan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1807

311C90: patient profiles and typical case histories of migraine management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1807

10.1177/0333102497017S1807

21 January 2018

Identifiers

DOI

0 references

1 reference